NACDS announces 2013-2014 officers, welcomes new members to executive committee, board
PALM BEACH, Fla. — During the National Association of Chain Drug Stores Annual Meeting today, the association elected the new officers, two new executive committee members and four new board of directors members for the coming year.
Robert Narveson, president and CEO of Thrifty White Pharmacy, was elected as the new NACDS chairman of the board of directors, succeeding Gregory Wasson, president and CEO of Walgreens.
In addition, John Standley — chairman, president and chief executive officer of Rite Aid — was elected vice chairman, and Juan Ortiz, CEO of Navarro Discount Pharmacies, was elected treasurer.
“We are pleased to welcome Bob Narveson as NACDS chairman of the board of directors,” said NACDS president and CEO Steve Anderson. “Serving as a board officer and chairman of the NACDS Political Action Committee, Bob has displayed an incredible commitment to community pharmacy and NACDS. We look forward to working with him in his new role as chairman of the board in the coming year.”
In addition to the election of the new officers for one-year terms, the NACDS board elected John Agwunobi — SVP and president of health and wellness at Wal-Mart — and Juan Ortiz as new executive committee members.
Four new board of directors members were also elected: Randy Edeker, chairman and CEO of Hy-Vee; Dijuana Lewis, SVP healthcare solutions for the health-and-wellness division at Wal-Mart; Ken Martindale, CEO of Rite Aid; and Martin Otto, chief merchant and CFO of H-E-B.
These four new board members will join the other 22 members of the NACDS board of directors to develop NACDS’ policies and priorities.
Target customers frequently turn to pharmacists for allergy advice, survey finds
MINNEAPOLIS — More than half of allergy sufferers seek advice from pharmacists and doctors, a new survey by Target has found.
The survey found that of the 70% of American adults with spring allergies, 56% seek advice from a pharmacist or doctor. The 2,111-person survey was conducted online by Harris Interactive on behalf of the mass merchandise retailer. The survey also found that 34% of respondents said the worst parts of the spring allergy season were the side effects of medication, while 32% cited being unable to enjoy time outside and another 32% cited sleep interference, but only 25% said they were prepared for allergy season.
"As Americans begin to take more control over their healthcare choices, pharmacists have emerged as a valuable and trusted resource," Target associate medical director Kevin Ronneberg said. "Target pharmacists serve as a partner on both sides of the counter and can help guests find relief by identifying the best over-the-counter products to alleviate and treat specific allergy symptoms and triggers."
Surveying 1,200 of its own pharmacists on the top concerns expressed by customers with allergies, Target found that pharmacists frequently had to answer questions about drugs they would recommend to alleviate symptoms, the difference between private label and branded OTC medicines, and which medicines are safe for children.
Three-stage pacifier brand, popular in Europe, to be marketed in U.S.
NEW YORK — Difrax is selling its brand of three-stage pacifiers in the United States, the company said.
The company said it would start marketing the pacifiers after a successful run in Europe. The pacifiers, which are available in classic and orthodontic styles, have a three-stage design to accommodate babies’ growth and development, including a soft-nipple stage for newborns and babies ages 6 months; another stage with a larger and slightly firmer nipple for those ages 6 to 18 months; and a solid nipple for those ages 18 months and older that is described as less satisfying and designed to prepare children for weaning.
Both pacifier styles have a butterfly shape to prevent the nose from being obstructed and holes to allow airflow and reduce skin irritation. The three stages sell for $5.49, $5.99 and $5.99, respectively.